| Serial Number | 79338771 |
| Word Mark | CCRM |
| Filing Date | Friday, November 19, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 28, 2023 |
| Registration Number | 7226858 |
| Registration Date | Tuesday, November 28, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 12, 2023 |
| Goods and Services | Custom manufacture of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms |
| Pseudo Mark | CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE |
| Goods and Services | Business planning; providing market intelligence services |
| Goods and Services | Reviewing standards and practices to assure compliance with regulations related to the research, development, manufacture and sale of products in the health care and medical fields and the administration of health care services |
| Goods and Services | Development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development of new biotechnological products for others for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; development of new biotechnological products for others for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; providing medical and scientific research information in the field of clinical trials; medical and scientific research, namely, conducting clinical trials for others; genetic testing for scientific research purposes in the field of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; scientific research in the field of genetic engineering, namely, research of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 22, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 22, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 22, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 22, 2022 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Centre for Commercialization of Regenerative Medicine |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 54 - NOT AVAILABLE |
| Address | CA |
| Party Name | Centre for Commercialization of Regenerative Medicine |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 54 - NOT AVAILABLE |
| Address | CA |
| Party Name | Centre for Commercialization of Regenerative Medicine |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 54 - NOT AVAILABLE |
| Address | CA |
| Event Date | Event Description |
| Monday, April 8, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Saturday, March 2, 2024 | GENERIC MADRID TRANSACTION SENT TO IB |
| Saturday, March 2, 2024 | GENERIC MADRID TRANSACTION CREATED |
| Wednesday, February 28, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 28, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 28, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Monday, October 16, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, September 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, September 12, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, September 12, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 12, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 23, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 23, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 23, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 20, 2023 | ASSIGNED TO EXAMINER |
| Friday, June 9, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 8, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 8, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, May 7, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, January 4, 2023 | REFUSAL PROCESSED BY IB |
| Friday, December 9, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, December 9, 2022 | REFUSAL PROCESSED BY MPU |
| Wednesday, September 28, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, September 27, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 31, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, April 26, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, April 22, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 21, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |